Get startedLog in
    Picture of AbbVie logo

    ABBV — AbbVie News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Adarx Pharmaceuticals: IPO Price Expected Between $15 And $17 Per Share

    Picture of AbbVie logoAbbVie
    21/09/2026 12:58
    BRIEF-Adarx Pharmaceuticals: IPO Price Expected Between $15 And $17 Per Share
    Sept 21 (Reuters) - AbbVie Inc. ABBV.N:
    • ADARX PHARMACEUTICALS - IPO PRICE EXPECTED BETWEEN $15 AND $17 PER SHARE - SEC FILING
    • ADARX PHARMACEUTICALS - TO OFFER 21,875,000 SHARES IN IPO - SEC FILING
    • ADARX PHARMACEUTICALS - ABBVIE TO PURCHASE 5,007,844 SHARES BASED ON IPO SIZE - SEC FILING
    Source text: [ID:n0001193125-26-396007]
    Further company coverage: ABBV.N

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on AbbVie

    See all news